Business Description
Novavax Inc
NAICS : 325414
SIC : 2836
ISIN : US6700024010
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.48 | |||||
Equity-to-Asset | -0.4 | |||||
Debt-to-Equity | -0.32 | |||||
Debt-to-EBITDA | -0.47 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -4.53 | |||||
Beneish M-Score | 4.47 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 142.1 | |||||
3-Year EBITDA Growth Rate | 11.2 | |||||
3-Year EPS without NRI Growth Rate | 9.4 | |||||
3-Year FCF Growth Rate | -65.6 | |||||
Future 3-5Y Total Revenue Growth Rate | 18.66 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 65.27 | |||||
9-Day RSI | 50.34 | |||||
14-Day RSI | 46.58 | |||||
6-1 Month Momentum % | -28.05 | |||||
12-1 Month Momentum % | -46.32 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.7 | |||||
Quick Ratio | 0.67 | |||||
Cash Ratio | 0.35 | |||||
Days Inventory | 43.67 | |||||
Days Sales Outstanding | 106.43 | |||||
Days Payable | 140.81 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -25.3 | |||||
Shareholder Yield % | -17.62 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 50.43 | |||||
Operating Margin % | -81.69 | |||||
Net Margin % | -78.6 | |||||
FCF Margin % | -112.21 | |||||
ROA % | -30.48 | |||||
ROIC % | -30.77 | |||||
ROC (Joel Greenblatt) % | -120.68 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.67 | |||||
EV-to-EBIT | -0.47 | |||||
EV-to-EBITDA | -0.51 | |||||
EV-to-Revenue | 0.36 | |||||
EV-to-Forward-Revenue | 0.26 | |||||
EV-to-FCF | -0.32 | |||||
Price-to-Median-PS-Value | 0.03 | |||||
Earnings Yield (Greenblatt) % | -212.77 | |||||
FCF Yield % | -131.78 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Novavax Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 638.782 | ||
EPS (TTM) (€) | -5.179 | ||
Beta | 1.13 | ||
Volatility % | 49.31 | ||
14-Day RSI | 46.58 | ||
14-Day ATR (€) | 0.169349 | ||
20-Day SMA (€) | 4.0423 | ||
12-1 Month Momentum % | -46.32 | ||
52-Week Range (€) | 3.413 - 10.17 | ||
Shares Outstanding (Mil) | 139.95 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Novavax Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Novavax Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Novavax Inc Frequently Asked Questions
What is Novavax Inc(STU:NVV1)'s stock price today?
When is next earnings date of Novavax Inc(STU:NVV1)?
Does Novavax Inc(STU:NVV1) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |